表紙SALE
市場調查報告書

冠狀病毒診斷的全球市場:競爭、預測、機會 - 各檢驗類型(分子,血清),用戶(單一、複數),整體所需時間,最終用途,地區

Global Coronavirus Diagnostics Market, By Type of Test (Molecular v/s Serology), User (Single v/s Multiple), Full Test Time, End User, Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 932039
出版日期 內容資訊 英文 115 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

冠狀病毒診斷的全球市場:競爭、預測、機會 - 各檢驗類型(分子,血清),用戶(單一、複數),整體所需時間,最終用途,地區 Global Coronavirus Diagnostics Market, By Type of Test (Molecular v/s Serology), User (Single v/s Multiple), Full Test Time, End User, Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年04月01日內容資訊: 英文 115 Pages
簡介

新型冠狀病毒感染疾病,從動物傳人、人傳人,感染擴展開來。主要的感染途徑是飛沫感染和接觸感染。第一個的病例是2019年12月在中國的武漢報告,從那之後,感染擴展到世界各地感染者數上升到數百萬人。至2020年4月9日確認的感染人數是150萬人,回復人數約33萬人,死亡人數約8萬8,000人。全球冠狀病毒診斷市場預計以驚人的成長率發展,市場規模至2025年將達到22億美元。新型冠狀病毒感染疾病的全球感染者的劇增成為這個市場成長的促進因素。

本報告提供全球冠狀病毒診斷市場調查,市場概要,各檢驗類型、用戶、整體所需時間、最終用途、地區的市場規模的變化與預測,市場成長要素及課題,市場機會,市場佔有率,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

  • 品牌認知度
  • 產品認知度
  • 顧客滿意度分析
  • 價格分析
  • 未滿足需求/課題

第5章 全球冠狀病毒診斷市場概要

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各檢驗類型
      • 分子檢驗
      • 血清檢驗
    • 各用戶
      • 單一
      • 複數
    • 各總所需時間
      • 不滿60分
      • 1小時∼12小時
      • 13小時∼24小時
      • 1日以上
    • 各最終用途
      • 醫院
      • 公共衛生研究所
      • 民間研究所
      • 診療所
      • 其他
    • 各企業
    • 各地區
  • 給藥途徑市場地圖

第6章 歐洲的冠狀病毒診斷市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各最終用途
    • 各國
  • 市場分析:各國
    • 義大利
    • 西班牙
    • 德國
    • 法國
    • 英國

第7章 北美的冠狀病毒診斷市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各最終用途
    • 各國
  • 市場分析:各國
    • 美國
    • 加拿大
    • 墨西哥

第8章 亞太地區的冠狀病毒診斷市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各最終用途
    • 各國
  • 市場分析:各國
    • 中國
    • 韓國
    • 澳洲
    • 印度
    • 日本
    • 泰國

第9章 中東、非洲的冠狀病毒診斷市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各最終用途
    • 各國
  • 市場分析:各國
    • 伊朗
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非

第10章 南美的冠狀病毒診斷市場展望

  • 市場規模與預測
    • 以金額為準
  • 市場佔有率與預測
    • 各檢驗類型
    • 各用戶
    • 各最終用途
    • 各國
  • 市場分析:各國
    • 巴西
    • 阿根廷
    • 哥倫比亞

第11章 市場動態

  • 成長要素
  • 課題

第12章 市場趨勢

第13章 競爭情形

  • Roche Diagnostics
  • Abbott
  • Cepheid Inc
  • Bio-Rad Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Lonza
  • bioMerieux
  • Mammoth Biosciences
  • Hologic
  • Qiagen
  • GSK Biologicals
  • PerkinElmer
  • Ortho-Clinical Diagnostics
  • Thermo Fischer Scientific
  • Mylab
  • Altona Diagnostics

第14章 策略性推薦事項

目錄
Product Code: 4574

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 9th April 2020, the total number of coronavirus cases crossed 1.5 million, globally, of which around 330,000 had recovered and over 88,000 people had died.

Global coronavirus diagnostics market is expected to grow at a formidable rate and cross $ 2.2 billion by 2025. The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

Europe and North America are expected to witness significant growth during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include Roche Diagnostics, Abbott, Cepheid Inc, Bio-Rad Laboratories, Beckman Coulter, Becton, Dickinson and Company, Lonza, bioMerieux, Mammoth Biosciences, Hologic, Qiagen, GSK Biologicals, PerkinElmer, Ortho-Clinical Diagnostics, Thermo Fischer Scientific, Mylab, Altona Diagnostics and others.

Years considered for this report:

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To estimate and forecast the market size of global coronavirus diagnostics market from 2020 to 2025.
  • To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
  • To identify dominant regions and segments in the global coronavirus diagnostics market.
  • To identify drivers and challenges for global coronavirus diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
  • To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
  • To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to coronavirus diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type of Test:

Molecular

Serology

  • Market, By User:

Single

Multiple

  • Market, By Full Test Time:

Less Than 60 Minutes

1 Hour - 12 Hours

13 Hours - 24Hours

More Than 1 Day

  • Market, By End User:

Hospitals

Public Health Labs

Private or Commercial Labs

Physician Labs

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Iran

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness (Aided/Unaided)
  • 4.2. Product Awareness
  • 4.3. Customer Satisfaction Analysis
  • 4.4. Pricing Analysis
  • 4.5. Unmet Needs/Challenges

5. Global Coronavirus Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Test (Molecular v/s Serology)
    • 5.2.2. By User (Single v/s Multiple)
    • 5.2.3. By Full Test Time (Less Than 60 Minutes, 1 Hours to 12 Hours, 13 Hours-24Hours, More Than 1 Days)
    • 5.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
    • 5.2.5. By Company (2020)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Europe Coronavirus Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Test
    • 6.2.2. By User
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. Italy Coronavirus Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Test
        • 6.3.1.2.2. By User
        • 6.3.1.2.3. By End User
    • 6.3.2. Spain Coronavirus Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Test
        • 6.3.2.2.2. By User
        • 6.3.2.2.3. By End User
    • 6.3.3. Germany Coronavirus Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Test
        • 6.3.3.2.2. By User
        • 6.3.3.2.3. By End User
    • 6.3.4. France Coronavirus Diagnostics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type of Test
        • 6.3.4.2.2. By User
        • 6.3.4.2.3. By End User
    • 6.3.5. United Kingdom Coronavirus Diagnostics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type of Test
        • 6.3.5.2.2. By User
        • 6.3.5.2.3. By End User

7. North America Coronavirus Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Test
    • 7.2.2. By User
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Coronavirus Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Test
        • 7.3.1.2.2. By User
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Coronavirus Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Test
        • 7.3.2.2.2. By User
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Coronavirus Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Test
        • 7.3.3.2.2. By User
        • 7.3.3.2.3. By End User
        • 7.3.3.2.4.

8. Asia-Pacific Coronavirus Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Test
    • 8.2.2. By User
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Coronavirus Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Test
        • 8.3.1.2.2. By User
        • 8.3.1.2.3. By End User
    • 8.3.2. South Korea Coronavirus Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Test
        • 8.3.2.2.2. By User
        • 8.3.2.2.3. By End User
    • 8.3.3. Australia Coronavirus Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Test
        • 8.3.3.2.2. By User
        • 8.3.3.2.3. By End User
    • 8.3.4. India Coronavirus Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Test
        • 8.3.4.2.2. By User
        • 8.3.4.2.3. By End User
    • 8.3.5. Japan Coronavirus Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Test
        • 8.3.5.2.2. By User
        • 8.3.5.2.3. By End User
    • 8.3.6. Thailand Coronavirus Diagnostics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type of Test
        • 8.3.6.2.2. By User
        • 8.3.6.2.3. By End User

9. Middle East and Africa Coronavirus Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Test
    • 9.2.2. By User
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. Iran Coronavirus Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Test
        • 9.3.1.2.2. By User
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Coronavirus Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Test
        • 9.3.2.2.2. By User
        • 9.3.2.2.3. By End User
    • 9.3.3. Saudi Arabia Coronavirus Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Test
        • 9.3.3.2.2. By User
        • 9.3.3.2.3. By End User
    • 9.3.4. South Africa Coronavirus Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type of Test
        • 9.3.4.2.2. By User
        • 9.3.4.2.3. By End User

10. South America Coronavirus Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Test
    • 10.2.2. By User
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Coronavirus Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Test
        • 10.3.1.2.2. By User
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Coronavirus Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Test
        • 10.3.2.2.2. By User
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Coronavirus Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Test
        • 10.3.3.2.2. By User
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Roche Diagnostics
  • 13.2. Abbott
  • 13.3. Cepheid Inc
  • 13.4. Bio-Rad Laboratories
  • 13.5. Beckman Coulter
  • 13.6. Becton, Dickinson and Company
  • 13.7. Lonza
  • 13.8. bioMerieux
  • 13.9. Mammoth Biosciences
  • 13.10. Hologic
  • 13.11. Qiagen
  • 13.12. GSK Biologicals
  • 13.13. PerkinElmer
  • 13.14. Ortho-Clinical Diagnostics
  • 13.15. Thermo Fischer Scientific
  • 13.16. Mylab
  • 13.17. Altona Diagnostics

14. Strategic Recommendations

List of Figures

  • Figure 1: Global Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 2: Global Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 3: Global Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 4: Global Coronavirus Diagnostics Market Share, By Full Test Time, 2020E-2025F
  • Figure 5: Global Coronavirus Diagnostics Market Share, By End - user, 2020E-2025F
  • Figure 6: Global Coronavirus Diagnostics Market Share, By Region, 2020E-2025F
  • Figure 7: Global Coronavirus Diagnostics Market Share, By Company, 2020E-2025F
  • Figure 8: Europe Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 9: Europe Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 10: Europe Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 11: Europe Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 12: Europe Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 13: Italy Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 14: Italy Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 15: Italy Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 16: Italy Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 17: Spain Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 18: Spain Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 19: Spain Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 20: Spain Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 21: Germany Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 22: Germany Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 23: Germany Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 24: Germany Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 25: France Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 26: France Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 27: France Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 28: France Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 29: United Kingdom Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 30: United Kingdom Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 31: United Kingdom Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 32: United Kingdom Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 33: North America Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 34: North America Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 35: North America Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 36: North America Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 37: North America Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 38: United States Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 39: United States Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 40: United States Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 41: United States Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 42: Canada Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 43: Canada Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 44: Canada Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 45: Canada Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 46: Mexico Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 47: Mexico Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 48: Mexico Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 49: Mexico Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 50: Asia-Pacific Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 51: Asia-Pacific Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 52: Asia-Pacific Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 53: Asia-Pacific Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 54: Asia-Pacific Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 55: China Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 56: China Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 57: China Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 58: China Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 59: South Korea Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 60: South Korea Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 61: South Korea Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 62: South Korea Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 63: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 64: Australia Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 65: Australia Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 66: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025
  • Figure 67: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 68: India Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 69: India Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 70: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025

Figure 71: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F

  • Figure 72: Japan Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 73: Japan Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 74: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 75: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 76: Thailand Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 77: Thailand Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 78: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 79: Middle East & Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 80: Middle East & Africa Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 81: Middle East & Africa Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 82: Middle East & Africa Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 83: Middle East & Africa Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 84: Iran Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 85: Iran Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 86: Iran Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 87: Iran Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 88: UAE Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 89: UAE Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 90: UAE Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 91: UAE Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 92: Saudi Arabia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 93: Saudi Arabia Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 94: Saudi Arabia Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 95: Saudi Arabia Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 96: South Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 97: South Africa Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 98: South Africa Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 99: South Africa Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 100: South America Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 101: South America Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 102: South America Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 103: South America Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 104: South America Coronavirus Diagnostics Market Share, By Country, 2020E-2025F
  • Figure 105: Brazil Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 106: Brazil Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 107: Brazil Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 108: Brazil Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 109: Argentina Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 110: Argentina Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 111: Argentina Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 112: Argentina Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F
  • Figure 113: Colombia Coronavirus Diagnostics Market Size, By Value (USD Million), 2020E-2025F
  • Figure 114: Colombia Coronavirus Diagnostics Market Share, By Type of Test, 2020E-2025F
  • Figure 115: Colombia Coronavirus Diagnostics Market Share, By User, 2020E-2025F
  • Figure 116: Colombia Coronavirus Diagnostics Market Share, By End-User, 2020E-2025F